These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8927337)

  • 1. [Fibrinolysis and vascular diseases].
    Udvardy M; Boda Z
    Orv Hetil; 1996 Aug; 137(34):1851-5. PubMed ID: 8927337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW; Catto AJ; Carter AM; Grant PJ
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The endogenic and exogenic fibrinolytic activity of the blood in arteriovascular diseases].
    Perlick E; Wilfert K; Zimmermann J; Vitzthum HE
    Z Gesamte Inn Med; 1966 Apr; 21(7):198-201. PubMed ID: 5985204
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
    J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
    Couderc R; Maachi M
    J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fibrinogen and fibrinolysis in peripheral arterial disease.
    Paraskevas KI; Baker DM; Vrentzos GE; Mikhailidis DP
    Thromb Res; 2008; 122(1):1-12. PubMed ID: 17669476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between blood coagulation markers, atherothrombosis and dementia.
    Gupta A; Pansari K
    Int J Clin Pract; 2003 Mar; 57(2):107-11. PubMed ID: 12661793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic and pharmacologic implications of fibrinolysis.
    Kwaan HC
    Artery; 1979 Mar; 5(3):285-90. PubMed ID: 526134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease.
    Agirbasli M
    Int J Clin Pract; 2005 Jan; 59(1):102-6. PubMed ID: 15707473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of Von Willebrand factor in pancreatic graft thrombosis after kidney-pancreas transplantation: a retrospective study.
    Kessler L; Wiesel ML; Boudjema K; Lutun E; Moulin B; Cazenave JP; Wolf P; Pinget M
    Clin Transplant; 1998 Feb; 12(1):35-42. PubMed ID: 9541421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic risk factor clustering and insulin resistance in healthy male relatives of men with intermittent claudication.
    Parry DJ; Grant PJ; Scott DJ
    Br J Surg; 2006 Mar; 93(3):315-24. PubMed ID: 16498597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.